retatrutide news today recency 3 The Thriving Black Market for a Powerful Weight Loss Drug glp-1 news today recency 3

10.1136/gut.2004.059741 132

No FDA-approved semaglutide patch currently exists for weight loss

The applicability of thyroid c-cell tumors in rats and humans is not clear, and it cannot be established just by clinical trials or nonclinical studies

However, this is early research, and more studies are needed to confirm these findings in larger and more diverse groups

These agents are FDA-approved primarily for the management of type 2 diabetes mellitus and, for specific products (Wegovy, Saxenda, Zepbound), for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity